First in-human study of drug targeting brain inflammation supports further development

MW189 blocks abnormal inflammation in the brain that is known to contribute to injury- and disease-induced neurologic impairments in a number of acute and chronic brain disorders. This study examined MW189 in healthy adult volunteers.